Rapid recovery of self-stimulation responding from depression by clozapine is prevented by the α2-adrenoceptor agonist, clonidine

Behavioural Pharmacology

Volumn 10, Issue 5, 1999, Pages 475-482

  Montgomery, A M J ^a,c   Grottick, A J ^a,b   Herberg, L J ^b  

^a LONDON METROPOLITAN UNIVERSITY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF GREENWICH   (United Kingdom)

Author keywords

Alpha2 adrenoceptors; Atypical neuroleptics; Clonidine; Clozapine; Extrapyramidal side effects; Idazoxan; Rat; Schizophrenia; Self stimulation

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHLORPROMAZINE; CLONIDINE; CLOZAPINE; HALOPERIDOL; IDAZOXAN; NEUROLEPTIC AGENT; RISPERIDONE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; EXTRAPYRAMIDAL SYMPTOM; INSTRUMENTAL CONDITIONING; MALE; NERVE STIMULATION; NONHUMAN; RAT; SELF STIMULATION; SUBCUTANEOUS DRUG ADMINISTRATION; VENTRAL TEGMENTUM;

EID: 0032871854     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-199909000-00006     Document Type: Article

References (23)

1. Agars K, Kokkinidis L (1992). Scopolamine increases non-reinforced behavior in an intracranial self-stimulation discrimination paradigm. Pharmacol Biochem Behav 43:657-660.
2. Anden N-E (1972). Dopamine turnover in the corpus striatum and the limbic system after treatment with neuroleptic and antiacetylcholine drugs. J Pharm Pharmacol 24:905-906.
3. Anon (1997). Olanzapine, sertindole and schizophrenia. Drugs Ther Bull 35:81-83.
4. Fouriezos G, Wise RA (1976). Pimozide-induced extinction of intra-cranial self-stimulation: Response patterns rule out motor or performance deficits. Brain Res 103:377-380.
5. 2 receptor stimulation. Pharmacol Biochem Behav 58:1045-1049.
6. Herberg LJ, Stephens DN, Franklin KBJ (1976). Catecholamines and self-stimulation: evidence suggesting a reinforcing role for noradrenaline and a motivating role for dopamine. Pharmacol Biochem Behav 4:575-582.
7. Herberg LJ, Montgomery AMJ, Rose IC (1993). Tolerance and sensitization to stimulant and depressant effects of nicotine in intracranial self-stimulation in the rat. Behav Pharmacol 4:419-427.
8. 2-Adrenoceptor antagonism may contribute to the atypical properties of risperidone: Experimental support for the Nutt case. J Psychopharmacol 9:281-283.
9. Kane J, Honigfeld G, Singer J, Meltzer HY (1988). Clozapine for the treatment-resistant schizophrenic: A double blind comparison with chlorpromazine. Arch Gen Psychiatry 45:789-796.
10. 2 receptors. Psychopharmacology 112:S40-S54.
11. 2 antagonist, augments fluphenazine in schizophrenic patients: a pilot study. J Clin Psychopharmacol 13:264-267.
12. Meltzer HY (1992). The importance of serotonin dopamine interactions in the action of clozapine. Br J Psychiatry 160:22-29.
13. Moore NA, Tye NC, Axton MS, Risius FC (1992). The behavioural pharmacology of olanzapine, a novel 'atypical' antipsychotic agent. J Pharmacol Exp Ther 262:545-551.
14. 2-adrenoceptor antagonism account for the therapeutic advantage of new antipsychotics? J Psychopharmacol 8:193-195.
15. Paxinos G, Watson C (1986). The Rat Brain in Stereotaxic Coordinates (2nd edn). Sydney: Academic Press.
16. Sahakian BJ, Hodges J (1994). Idazoxan improves cognitive function in frontal lobe dementia. J Neurol Neurosurg Psychiatry 57:120-121.
17. Sanger DJ (1986). Response decrement patterns after neuroleptic and non-neuroleptic drugs. Psychopharmacology 89:98-104.
18. Sanger DJ, Perrault G (1995). Effects of typical and atypical antipsychotic drugs on response decrement patterns in rats. J Pharmacol Exp Ther 272:708-713.
19. Schotte A, Janssen PFM, Gommeren W et al. (1996). Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptor binding. Psychopharmacology 124:57-73.
20. Schultz SK, Andeasen NC (1999). Schizophrenia. Lancet 353:1425-1430.
21. Sumiyoshi T, Kido H, Sakamoto H et al. (1994). In vivo dopamine-D2 and serotonin-5-HT2 receptor binding study of risperidone and haloperidol. Pharmacol Biochem Behav 47:553-557.
22. Wauquier A (1970). Neuroleptics and brain self-stimulation. Int Rev Neurobiol 21:335-403
23. Wauquier A (1976). The influence of psychoactive drugs on brain stimulation in rats: a review. In: Brain Stimulation Reward. Waquier A, Rolls ET (editors). Amsterdam: North Holland, pp. 123-170.